• user warning: Table './fnndrupaldev/term_node' is marked as crashed and last (automatic?) repair failed query: SELECT t.* FROM term_node r INNER JOIN term_data t ON r.tid = t.tid INNER JOIN vocabulary v ON t.vid = v.vid WHERE r.vid = 531776 ORDER BY v.weight, t.weight, t.name in /var/www/www.fnno.com/htdocs/modules/taxonomy/taxonomy.module on line 617.
  • user warning: Table './fnndrupaldev/sessions' is marked as crashed and last (automatic?) repair failed query: SELECT COUNT(sid) AS count FROM sessions WHERE timestamp >= 1413897526 AND uid = 0 in /var/www/www.fnno.com/htdocs/includes/session.inc on line 111.
  • user warning: Table './fnndrupaldev/sessions' is marked as crashed and last (automatic?) repair failed query: SELECT DISTINCT u.uid, u.name, s.timestamp FROM users u INNER JOIN sessions s ON u.uid = s.uid WHERE s.timestamp >= 1413897526 AND s.uid > 0 ORDER BY s.timestamp DESC in /var/www/www.fnno.com/htdocs/modules/user/user.module on line 765.

Shares of Salix Pharmaceuticals Have Risen Above Previous 52-Week High

Published on Thu, 07/11/2013 - 18:13
By Peter Chu

Shares of Salix Pharmaceuticals (NASDAQ:SLXP) traded at a new 52-week high today of $69.66. This new high was reached on below average trading volume as 357,000 shares traded hands, while the average 30-day volume is approximately 600,000 shares.

Salix Pharmaceuticals (NASDAQ:SLXP) is currently priced 13.9% above its average consensus analyst price target of $59.39. Salix Pharmaceuticals shares have support at the 50-day moving average (MA) of $61.69 and additional support at the 200-day MA of $49.25.

In the past 52 weeks, Salix Pharmaceuticals share prices have been bracketed by a low of $37.52 and a high of $69.66 and are now at $69.02, 84% above that low price. In the last five trading sessions, the 50-day moving average (MA) has climbed 1.7% while the 200-day MA has risen 0.8%.

Salix Pharmaceuticals, Ltd. develops and markets prescription pharmaceutical products for the treatment of gastrointestinal diseases. The Company's COLAZAL product is an anti-inflammatory drug used for the treatment of mildly to moderately active ulcerative colitis.

By Peter Chu
pchu@fnno.com

Latest News from FNNO

Best Relative Performance in the Special...

Here are the top 5 stocks in the Specialty Chemicals industry ranked by performance. W ...

Hospitality Properties Trust is Among th...

We looked at the Specialized REITs industry and measured relative performance to find t ...

Best Relative Performance in the Special...

Here are the top 5 stocks in the Specialized Finance industry ranked by performance. W ...

Possible Bearish Inside Day Candle Patte...

Analysts have spotted a possible bearish inside day candle pattern in Tesco (NASDAQ:TES ...

Shares of Dr Pepper Snapple Rank the Hig...

Here are the top 5 stocks in the Soft Drinks industry ranked by performance. We compil ...

Possible Bearish Inside Day Candle Patte...

Analysts have spotted a possible bearish inside day candle pattern in Mead Johnson Nutr ...

Mellanox Technologies has the Best Relat...

We looked at the Semiconductors industry and measured relative performance to find the ...

Con-way has Relatively Underperformed it...

Here are 5 stocks in the Trucking industry ranked by performance. We compiled the trad ...